Cargando…
Development of a next-generation chikungunya virus vaccine based on the HydroVax platform
Chikungunya virus (CHIKV) is an emerging/re-emerging mosquito-borne pathogen responsible for explosive epidemics of febrile illness characterized by debilitating polyarthralgia and the risk of lethal infection among the most severe cases. Despite the public health risk posed by CHIKV, no vaccine is...
Autores principales: | Slifka, Dawn K., Raué, Hans-Peter, Weber, Whitney C., Andoh, Takeshi F., Kreklywich, Craig N., DeFilippis, Victor R., Streblow, Daniel N., Slifka, Mark K., Amanna, Ian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286250/ https://www.ncbi.nlm.nih.gov/pubmed/35788221 http://dx.doi.org/10.1371/journal.ppat.1010695 |
Ejemplares similares
-
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
por: Woods, Christopher W., et al.
Publicado: (2019) -
Role of Multivalency and Antigenic Threshold in Generating Protective Antibody Responses
por: Slifka, Mark K., et al.
Publicado: (2019) -
Passive Immunization
por: Slifka, Mark K., et al.
Publicado: (2018) -
Chikungunya Virus Infection Results in Higher and Persistent Viral Replication in Aged Rhesus Macaques Due to Defects in Anti-Viral Immunity
por: Messaoudi, Ilhem, et al.
Publicado: (2013) -
Active Circulation of Corynebacterium ulcerans among Nonhuman Primates
por: Thomas, Archana, et al.
Publicado: (2022)